SOLICITATION NOTICE
B -- Measurement of Arsenic, Selenium, and Zinc in Toenail Samples from a Case-Control Study of Bladder Cancer in New England using Neutron Activation Analysis
- Notice Date
- 12/12/2005
- Notice Type
- Solicitation Notice
- NAICS
- 541710
— Research and Development in the Physical, Engineering, and Life Sciences
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Research Contracts Br., 6120 Executive Blvd. EPS Suite 600, Rockville, MD, 20852
- ZIP Code
- 20852
- Solicitation Number
- RFQ-NCI-60016-NG
- Response Due
- 12/21/2005
- Archive Date
- 1/5/2006
- Description
- This is a synopsis with a separately issued solicitation. The National Cancer Institute (NCI) plans to procure services regarding The Measurement of Arsenic, Selenium, and Zinc in Toenail Samples from a Case-Control Study of Bladder Cancer in New England using Neutron Activation Analysis. The supplies and services herein are commercial as defined in FAR Part 2, and this acquisition is being made in accordance with the test program for using commercial items as authorized in FAR Part 13. The North American Industry Classification System Code is 541710 and the business size standard is 500 employees. The National Cancer Institute, in collaboration with Dartmouth Medical School and several state Departments of Health, has completed the field work in a large case-control study of bladder cancer in Northern New England (Vermont, Maine, New Hampshire). This study was motivated by the persistent elevated rates of bladder cancer mortality and incidence in these three states. Arsenic in drinking water has emerged as a leading hypothesis that may explain the excess bladder cancer in New England. Low- to moderate levels of arsenic in bedrock aquifers used for drinking water, especially in private wells, occur in extended parts of the region. Based on what is known about the distribution of arsenic in Northern New England, and assuming a straight line extrapolation from the well-established risk of bladder cancer observed at high levels of exposure, the excess risk in rural areas appears to fit the expected level of risk. However, to date there have been no reliable assessments of bladder cancer risk in populations exposed to the lower levels of arsenic in water that are found in New England, and evaluation of this is an important part of the design of the NCI epidemiologic study. Scope: The contractor shall determine levels of arsenic, selenium, and zinc in toenail samples collected from subjects who participated in a case-control study of bladder cancer. The data will be used to estimate exposure to these elements in the context of the case-control study. Minimum number of samples is 1,650. Anticipated Period of Performance: One (1) year after initial award, only one award will be made. Solicitation: The RFQ must be requested by electronic mail or by fax. Telephone requests will not be accepted. Request for the RFQ shall be made to the attention of Malinda Holdcraft, Contract Specialist via electronic mail to holdcram@exchange.nih.gov or fax 301-402-4513. Requests shall include name of the contractor, complete mailing address, DUNS number, telephone and fax numbers, point of contact and electronic mail address, business size standard, and identify the RFQ requested as RFQ-NCI-60016-NG on all correspondence. The deadline of this synopsis is December 21, 2005 at 1 PM EST. The estimated issue date of the solicitation is December 27, 2005 and the estimated due date is January 13, 2005.
- Record
- SN00950156-W 20051214/051212211817 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |